Bottom line
What does VHT hold?
VHT held 407 positions as of May 31, 2026. Its largest holding is Eli Lilly & Co at 14.04% of the fund, and the top 10 positions add up to 51.9%. By asset type it is 100% stocks, 0% cash & short-term funds.
Updated Jul 29, 2026
VHT top 25 holdings
| # | Holding | Type | % of fund | Value |
|---|---|---|---|---|
| 1 | Eli Lilly & Co ELI LILLY & CO |
Stocks | 14.04% | $2.7B |
| 2 | Johnson & Johnson JOHNSON&JOHNSON |
Stocks | 8.47% | $1.6B |
| 3 | AbbVie Inc ABBVIE INC |
Stocks | 6.09% | $1.2B |
| 4 | UnitedHealth Group Inc UNITEDHEALTH GRP |
Stocks | 5.45% | $1.0B |
| 5 | Merck & Co Inc MERCK & CO |
Stocks | 4.66% | $885.0M |
| 6 | Thermo Fisher Scientific Inc THERMO FISHER |
Stocks | 2.93% | $555.7M |
| 7 | Amgen Inc AMGEN INC |
Stocks | 2.87% | $544.7M |
| 8 | Gilead Sciences Inc GILEAD SCIENCES |
Stocks | 2.64% | $500.9M |
| 9 | Intuitive Surgical Inc INTUITIVE SURGIC |
Stocks | 2.38% | $452.1M |
| 10 | Pfizer Inc PFIZER INC |
Stocks | 2.35% | $447.0M |
| 11 | Abbott Laboratories ABBOTT LABS |
Stocks | 2.35% | $447.0M |
| 12 | Bristol-Myers Squibb Co BRISTOL-MYER SQB |
Stocks | 1.84% | $349.6M |
| 13 | Danaher Corp DANAHER CORP |
Stocks | 1.84% | $348.7M |
| 14 | CVS Health Corp CVS HEALTH CORP |
Stocks | 1.83% | $346.9M |
| 15 | Vertex Pharmaceuticals Inc VERTEX PHARM |
Stocks | 1.80% | $341.1M |
| 16 | Stryker Corp STRYKER CORP |
Stocks | 1.66% | $315.3M |
| 17 | Medtronic PLC MEDTRONIC PLC |
Stocks | 1.50% | $284.1M |
| 18 | McKesson Corp MCKESSON CORP |
Stocks | 1.45% | $275.2M |
| 19 | Elevance Health Inc ELEVANCE HEALTH |
Stocks | 1.35% | $256.8M |
| 20 | Cigna Group/The THE CIGNA GROUP |
Stocks | 1.17% | $222.6M |
| 21 | Boston Scientific Corp BOSTON SCIENTIFC |
Stocks | 1.13% | $215.1M |
| 22 | Regeneron Pharmaceuticals Inc REGENERON PHARM |
Stocks | 1.00% | $190.7M |
| 23 | HCA Healthcare Inc HCA HEALTHCARE I |
Stocks | 0.96% | $181.6M |
| 24 | Edwards Lifesciences Corp EDWARDS LIFE |
Stocks | 0.79% | $150.7M |
| 25 | Cencora Inc CENCORA INC |
Stocks | 0.79% | $149.1M |
Source: SEC Form N-PORT, period ended May 31, 2026, filed Jul 29, 2026